R&D Systems™ Recombinant Human IL-12 (linked heterodimer) Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-12 (linked heterodimer) Protein is derived from HEK293. The Recombinant Human IL-12 (linked heterodimer) Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P29460.1 (IL-12p40), P29459.2 (IL-12p35)
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 3592
• Molecular Weight (g/mol): Observed M.W.: 63-75 kDa, under reducing conditions.
• Quantity: 10 μg
• Source: Human embryonic kidney cell, HEK293-derived human IL-12 protein Human IL-12p40 (Ile23-Ser328) (N-terminus) Accession # P29460.1 GSGSSRGGSGSGGSGGGGSK Human IL-12p35 (Arg23-Ser219) (N-terminus) Accession # P29459.2(C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Specific Reactivity: IL-12
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100-200 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.